Vision-related quality of life considering both eyes: results from the German population-based Gutenberg Health Study (GHS).
Journal
Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626
Informations de publication
Date de publication:
06 Jun 2019
06 Jun 2019
Historique:
received:
14
12
2018
accepted:
13
05
2019
entrez:
8
6
2019
pubmed:
7
6
2019
medline:
16
7
2019
Statut:
epublish
Résumé
Most definitions of visual impairment focus on the status of the better-seeing eye only, but this approach might underestimate the influence of the worse-seeing eye on the vision-related quality of life (VRQoL). We assessed distance-corrected visual acuity in both eyes and VRQoL using the "National Eye Institute 25-Item Visual Function Questionnaire" (NEI VFQ-25) in the German population-based Gutenberg Health Study. We calculated the Rasch-based visual functioning scale (VFS) and socioemotional scale (SES). We categorized the visual acuity of the better-seeing eye (BE) and worse-seeing eye (WE) as follows: (1) no visual impairment (VI) (< 0.32 logMAR)), (2) mild VI (0.32-0.5 logMAR), and (3) moderate to severe VI (> 0.5 logMAR). Next, the subjects were categorized as follows: both eyes with no VI (no/no), the better-seeing eye with no VI and the worse-seeing eye with mild VI (no/mild), no VI/severe VI (no/severe), both eyes with mild VI (mild/mild), light VI/severe VI (mild/severe), and both eyes with severe VI (severe/severe). We calculated the median scores for VFS and SES. We used linear regression to estimate the combined influence of BE/WE on VFS and SES. We included 11,941 participants (49.9% female, age range: 35-74 years) with information on VRQoL and visual acuity. The median VFS/SES scores were 90/100 (no/no VI group), 84/97 (no/mild group), 81/94 (no/severe group), 70/90 (mild/mild group), 67/74 (mild/severe group), and 63/76 (severe/severe group). These differences were supported by the regression analysis results. Relying on the function of the better-seeing eye considerably underestimates the impact of visual impairment on VRQoL.
Identifiants
pubmed: 31170975
doi: 10.1186/s12955-019-1158-1
pii: 10.1186/s12955-019-1158-1
pmc: PMC6554962
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
98Subventions
Organisme : Stiftung Rheinland-Pfalz für Innovation
ID : AZ 961-386261/733
Organisme : Boehringer Ingelheim
ID : n/a
Organisme : PHILIPS Medical Systems
ID : n/a
Références
Optom Vis Sci. 2000 Jan;77(1):13-24
pubmed: 10654854
Arch Ophthalmol. 2001 Jul;119(7):1050-8
pubmed: 11448327
J Cataract Refract Surg. 2001 Oct;27(10):1553-9
pubmed: 11687351
Am J Ophthalmol. 2004 Jul;138(1):91-108
pubmed: 15234287
Br J Ophthalmol. 2005 Mar;89(3):360-3
pubmed: 15722319
J Clin Epidemiol. 2006 Feb;59(2):201-7
pubmed: 16426956
Ophthalmology. 2006 Oct;113(10):1846-53
pubmed: 16889831
BMC Ophthalmol. 2008 Mar 06;8:4
pubmed: 18325083
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3629-35
pubmed: 19255158
Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):85-92
pubmed: 19763598
Ophthalmology. 2010 Apr;117(4):747-56.e4
pubmed: 20189654
J Cataract Refract Surg. 2010 May;36(5):718-32
pubmed: 20457362
Optom Vis Sci. 2010 Aug;87(8):543-8
pubmed: 20526224
Br J Ophthalmol. 2012 Jul;96(7):997-1002
pubmed: 22535331
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Jun;55(6-7):824-9
pubmed: 22736163
Int J Rehabil Res. 2013 Mar;36(1):48-55
pubmed: 22890293
Acta Ophthalmol. 2013 Sep;91(6):540-6
pubmed: 23171290
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):131-43
pubmed: 23275948
Health Qual Life Outcomes. 2013 Jan 24;11:10
pubmed: 23347793
Ophthalmic Epidemiol. 2013;20(1):33-9
pubmed: 23350553
Ophthalmologica. 2013;229(4):227-34
pubmed: 23614930
Optom Vis Sci. 2013 Aug;90(8):720-44
pubmed: 23873034
PLoS One. 2013 Dec 05;8(12):e81042
pubmed: 24339893
Ophthalmology. 2014 Jun;121(6):1246-51
pubmed: 24518613
J Cataract Refract Surg. 2014 May;40(5):774-84
pubmed: 24767911
Clin Ophthalmol. 2014 Sep 03;8:1703-9
pubmed: 25214763
Value Health. 2015 Jan;18(1):25-34
pubmed: 25595231
PLoS One. 2015 Mar 16;10(3):e0120476
pubmed: 25775251
Health Qual Life Outcomes. 2015 Sep 15;13:142
pubmed: 26370558
Ophthalmologe. 2016 Apr;113(4):283-8
pubmed: 27037554
Klin Monbl Augenheilkd. 2017 May;234(5):719-725
pubmed: 27459517
Health Qual Life Outcomes. 2016 Sep 20;14(1):132
pubmed: 27644469
Aging (Albany NY). 2017 Mar 28;9(3):1030-1040
pubmed: 28358301
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
Health Qual Life Outcomes. 2017 Aug 8;15(1):156
pubmed: 28789656
Ophthalmology. 2018 Aug;125(8):1149-1159
pubmed: 29548645
Arch Ophthalmol. 1993 May;111(5):686-91
pubmed: 8489454
J Refract Surg. 1997 Jul-Aug;13(4):388-91
pubmed: 9268940